Missing from the PBM hearings: value-based drug reimbursement
on Fri, 2019-04-12 12:42 Alyssa
This week, committees in both the Senate and House of Representatives used their power to shine a light on one of the most complex and opaque parts of the prescription drug equation: the practices of pharmaceutical benefit managers.
News Author:
Elizabeth J. Seeley
Shawn Bishop
Links:
[1] https://www.statnews.com/2019/04/11/pbm-hearings-value-based-drug-reimbursement/?utm_campaign=KHN%3A%20Daily%20Health%20Policy%20Report&utm_source=hs_email&utm_medium=email&utm_content=71705810&_hsenc=p2ANqtz-9iA1jxvQVoeSdIoLxxlXGI8DntG6UBZbvAw1aPXVZwJlT4ZIqb1hS9YnHqqoid0C0PveSAvp-xd36sXkUXO5nchnlq4g&_hsmi=71705810